Login / Signup

Adverse effects of delayed antimicrobial treatment and surgical source control in adults with sepsis: results of a planned secondary analysis of a cluster-randomized controlled trial.

Hendrik RüddelDaniel O Thomas-RüddelKonrad ReinhartFriedhelm BachHerwig GerlachMatthias LindnerJohn C MarshallPhilipp SimonManfred WeissFrank BloosDaniel Schwarzkopfnull null
Published in: Critical care (London, England) (2022)
Our findings suggest that management of sepsis is time critical both for antimicrobial therapy and source control. Also patients, who are not yet in septic shock, profit from early anti-infective treatment since it can prevent further deterioration. Trial registration ClinicalTrials.gov ( NCT01187134 ). Registered 23 August 2010, NCT01187134.
Keyphrases
  • septic shock
  • staphylococcus aureus
  • acute kidney injury
  • intensive care unit
  • study protocol
  • clinical trial
  • randomized controlled trial
  • phase iii
  • phase ii
  • replacement therapy
  • open label